“…Moreover, in DN patients or model mice and high glucose (HG)‐induced DN cellular model, miR‐30c (Gao et al, 2020), (J. Wang et al, 2016), miR‐30e (Zhao, Jia, et al, 2017), miR‐24 (H. Liu, Wang, et al, 2020), miR‐25 (Fu et al, 2010; H. Li et al, 2017), miR‐34a (X. Zhang et al, 2016), miR‐34c (Y. Zhao, Yin, et al, 2017), and miR‐423 (Xu, Zhang, et al, 2018) were also downregulated and its overexpression could promote the proliferation of renal cells and inhibit EMT by targeting Janus kinase‐1 (JAK1), connective tissue growth factor (CTGF), glioma pathogenesis related‐2 (GLIPR‐2), fibroblast growth factor 11 (FGF11), NADPH oxidase 4 (NOX4), the Notch signaling pathway and Snail1‐TGF‐ β 1 pathway, respectively, ultimately preventing renal fibrosis of DNs. However, miR‐34a (Xue et al, 2018; L. Zhang et al, 2014) and miR‐92b (Wang et al, 2020) were upregulated in the kidneys of DN mice or HG‐induced DN cellular model, which was related to glomerular hypertrophy, GAS1‐mediated mesangial cells proliferation, and SIRT1‐mediated fibrosis. Similarly, miR‐25 was found to be decreased in kidney tissues from patients with DN.…”